Two signaling pathways can increase Fas expression in human thymocytes

Blood

Volumn 92, Issue 4, 1998, Pages 1297-1307

  Moulian, Nathalie ^a   Bidault, Jocelyne ^a   Planché, Claude ^a   Berrih Aknin, Sonia ^a  

^a CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CYCLOHEXIMIDE; CYTOKINE; FAS ANTIGEN;

APOPTOSIS; ARTICLE; CELL LINE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; THYMOCYTE;

EID: 0032529524     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.4.1297     Document Type: Article

References (39)

1. Nagata S, Goldstein P: The Fas death factor. Science 267:1449, 1995
2. Kägi D, Vignaux F, Ledermann B, Bürki K, Depraetere V, Nagata S, Hengartner H, Goldstein P: Fas and perform pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265:528, 1994
3. Dhein J, Walczak H, Bäumler C, Debatin KM, Krammer PH: Autocrine T-cell suicide mediated by APO-1 (Fas/CD95). Nature 373:438, 1995
4. Brunner T, Mogil RG, LaFace D, Yoo NJ, Mahboubi A, Echeverri F, Martin SJ, Force WR, Lynch DH, Care CH, Green DR: Cell autonomous Fas (CD95)/Fas-ligand interaction mediate activation-induced apoptosis in T-cell hybridomas. Nature 373:441, 1995
5. Ju ST, Panka DJ, Cui H, Ettinger R, El-Khatib M, Sherr DH, Stanger BZ, Marshak-Rothstein A: Fas (CD95)/FasL interactions required for programmed cell death after activation. Nature 373:444, 1995
6. Ogasawara J, Suda T, Nagata S: Selective apoptosis of CD4+CD8+ thymocytes by the anti-Fas antibody. J Exp Med 181:485, 1995
7. Fisher GH, Lenardo MJ, Zuniga-Pflücker JC: Synergy between T cell receptor and Fas (CD95/APO-1) signaling in mouse thymocyte death. Cell Immunol 169:99, 1996
8. Zhou T, Fleck M, Müeller-Ladner U, Yang P, Wang Z, Gay S, Matsumoto S, Mountz JD: Kinetics of Fas-induced apoptosis in thymic organ culture. J Clin Immunol 17:74, 1997
9. Nishimura Y, Hirabayashi Y, Matsuzaki Y, Musette P, Ishii A, Nakauchi H, Inoue T, Yonehara S: In vivo analysis of Fas antigen-mediated apoptosis: Effects of agonistic anti-mouse Fas mAb on thymus, spleen and liver. Int Immunol 9:307, 1997
10. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S: Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314, 1992
11. Singer GG, Abbas AK: The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1:365, 1994
12. Sytwu HK, Liblau R, McDevitt HO: The roles of Fas/APO-1 (CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice. Immunity 5:17, 1996
13. Adachi M, Suematsu S, Suda T, Watanabe D, Fukuyama H, Ogasawara J, Tanaka T, Yoshida N, Nagata S: Enhanced and accelerated lymphoproliferation in Fas-null mice. Proc Natl Acad Sci USA 93:2131, 1996
14. Castro JE, Listman JA, Jacobson BA, Wang Y, Lopez PA, Ju S, Finn PW, Perkins DL: Fas modulation of apoptosis during negative selection of thymocytes. Immunity 5:617, 1996
15. Kishimoto H, Sprent J: Negative selection in the thymus includes semimature T cells. J Exp Med 185:263, 1997
16. Debatin KM, Süss D, Krammer PH: Differential expression of APO-1 on human thymocytes: Implications for negative selection? Eur J Immunol 24:753, 1994
17. Yonehara S, Nishimura Y, Kishil S, Yonehara M, Takazawa K, Tamatani T, Ishii A: Involvement of apoptosis antigen Fas in clonal deletion of human thymocytes. Int Immunol 6:1849, 1994
18. Moulian N, Bidault J, Truffault F, Yamamoto AM, Levasseur P, Berrih-Aknin S: Thymocyte Fas expression is dysregulated in Myasthenia gravis patients with anti-acetylcholine receptor antibody. Blood 89:3287, 1997
19. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima SI, Sameshima M, Hase A, Seto Y, Nagata S: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:223, 1991
20. Owen-Schaub LB, Yonehara S, Crump WL III, Grimm EA: DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell Immunol 140:197, 1992
21. Miyawaki Y, Uehara T, Nibu R, Tsuji T, Yachie A, Yonehara S, Taniguchi N: Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J Immunol 149:3753, 1992
22. McConkey DJ, Hartzell P, Amador-Perez JF, Orrenius S, Jondal M: Calcium-dependent killing of immature thymocytes by stimulation via the CD3/T cell receptor complex. J Immunol 143:1801, 1989
23. Punt JA, Osborne BA, Takahama Y, Sharrow SO, Singer A: Negative selection of CD4+CD8+ thymocytes by T cell receptor induced apoptosis required a costimulatory signal that can be provided by CD28. J Exp Med 179:709, 1994
24. Linsley PS, Ledbetter JA: The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol 11:191, 1993
25. Weyand CM, Goronzy J, Fathman CG: Modulation of CD4 by antigenic activation. J Immunol 138:1351, 1987
26. Schreiber LS, Crabtree GR: The mechanism of action of cyclosporin A and FK506. Immunol Today 13:136, 1992
27. Fadock VA, Voelker DR, Campell PA, Cohen JJ, Bratton DL, Henson PM: Exposition of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 148:2207, 1992
28. Vermes I, Haanen C, Steffens-Nakken H, Reutlingsperger C: A novel assay for apoptosis flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labeled annexin V. J Immunol Methods 184:39, 1995
29. Brunner T, Yoo NJ, La Face D, Ware CF, Green DR: Activation-induced cell death in murine T cell hybridomas. Differential regulation of Fas (CD95) versus Fas ligand expression by cyclosporin A and FK506. Int Immunol 8:1017, 1996
30. Oyaizu N, McCloskey TW, Than S, Hu R, Kalyanaraman VS, Pahwa S: Cross-linking of CD4 molecules upregulates Fas antigen expression in lymphocytes by inducing interferon-γ and tumor necrosis factor-α secretion. Blood 84:2622, 1994
31. Von Boehmer H: The selection of α-β heterodimeric T cell receptor for antigen. Immunol Today 7:333, 1986
32. Surh CD, Sprent J: T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature 372:100, 1994
33. Sato T, Shinji I, Kitada S, Reed JC: FAP-1: A protein tyrosine phosphatase that associates with Fas. Science 268:411, 1995
34. Mori S, Murakami-Mori K, Jewett A, Nakamura S, Bonavida B: Resistance of AIDS-associated Kaposi's sarcoma cells to Fas-mediated apoptosis. Cancer Res 56:1874, 1995
35. Chiba T, Takahashi S, Sato N, Ishii S, Kikuchi K: Fas-mediated apoptosis is modulated by intracellular glutathione in human T cells. Eur J Immunol 26:1164, 1996
36. Suda T, Tanaka M, Miwa K, Nagata S: Apoptosis of mouse naive T cells induced by recombinant soluble Fas ligand and activation-induced resistance to Fas ligand. J Immunol 157:3918, 1996
37. Suda T, Hashimoto H, Tanaka M, Ochi T, Nagata S: Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing. J Exp Med 186:2045, 1997
38. Andjelic S, Drappa J, Lacy E, Elkon KB, Nikolic-Zugic J: The onset of Fas expression parallels the acquisition of CDS and CD4 in fetal and adult ab thymocytes. Int Immunol 6:73, 1994
39. French LE, Wilson A, Hahne M, Viard I, Tschopp J, MacDonald HR: Fas ligand expression is restricted to nonlymphoid thymic components in situ. J Immunol 159:2196, 1997